期刊
DRUG DISCOVERY TODAY
卷 27, 期 1, 页码 117-133出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2021.09.004
关键词
Enzyme based therapy; Enzyme; Therapy; Biologic; Therapeutic enzymes; Clinical; Pre-clinical; Early investigational; Biotechnology; History
资金
- North Carolina Biotechnology Center [2018-BIG-6503]
- NIH Biotechnology Training Grant [T32GM008555]
- NIH [R61 AI140485-01]
Enzyme-based therapeutics have the potential to tap into vast enzyme biodiversity and treat various conditions, but face challenges in the development of new therapies, including overcoming technical barriers.
Enzyme-based therapeutics (EBTs) have the potential to tap into an almost unmeasurable amount of enzyme biodiversity and treat myriad conditions. Although EBTs were some of the first biologics used clinically, the rate of development of newer EBTs has lagged behind that of other biologics. Here, we review the history of EBTs, and discuss the state of each class of EBT, their potential clinical advantages, and the unique challenges to their development. Additionally, we discuss key remaining technical barriers that, if addressed, could increase the diversity and rate of the development of EBTs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据